The importance of modulating antitumor immune host responses following C5aR1 targeting has been highlighted in previous studies, and ourselves and others have observed reduced tumor burden in C5aR1–/– mice (data not shown) (28, 33, 34). This evidence concerns the gene C5AR1 and neoplasm.